Резултати

eNauka >  Results >  Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
Title: Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
Authors : Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S.  ; ...; (broj koautora 21)
Issue Date: 2023
Publication: The Lancet. Haematology
ISSN: 2352-3026 Lancet Haematology Search Idenfier
Publisher: [Oxford] : Elsevier Ltd.
Type: Article
Collation: vol. 10 br. 10 str. e813-e824
DOI: 10.1016/S2352-3026(23)00218-1
WoS-ID: 001088889800001
Scopus-ID: 2-s2.0-85172680628
PMID: 37793772
URI: https://enauka.gov.rs/handle/123456789/934853
URL: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00218-1/abstract
Project: European Myeloma Network
Janssen Research Development
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

41
SCOPUSTM
17
PubMed CentralTM
34
WEB OF SCIENCETM
Алт метрика
Dimensions
Unpaywall

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.